p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: An immunohistochemical study

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 1, 2006, Pages 69-73

  Kaabipour, Emad ^a   Haupt, Helen M ^a   Stern, Jere B ^b   Kanetsky, Peter A ^c   Podolski, Victoria F ^a   Martin, Anne Marie ^a,c  

^a PENNSYLVANIA HOSPITAL   (United States)

^b Dermatopathology Consultation Services   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; TUMOR MARKER;

AGED; ARTICLE; CANCER CELL; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; MALE; PATHOGENESIS; PROTEIN EXPRESSION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; THICKNESS; UNITED STATES;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL COUNT; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATOACANTHOMA; KERATOSIS; MALE; MIDDLE AGED; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 30444441424     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Schwartz RA. Keratoacanthoma. J Am Acad Dermatol. 1994;30:1-19.
2. Schwartz RA. Keratoacanthoma: a clinico-pathologic enigma. Dermatol Surg. 2004;30:326-333.
3. Melendez ND, Smoller BR, Morgan M. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas. Mod Pathol. 2003;16:8-13.
4. Takeda H, Kondo S. Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol. 2001;158:1633-1637.
5. Kerschmann RL, McCalmont TH, LeBoit PE. P53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Arch Dermatol. 1994;130:181-186.
6. Cain CT, Niemann TH, Argenyi ZB. Keratoacanthoma versus squamous cell carcinoma: an immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors. Am J Dermatopathol. 1995;174:324-331.
7. Putti TC, The M, Lee YS. Biologic behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers. Mod Pathol. 2004;17:468-475.
8. Skalova A, Michal M. Patterns of cell proliferation in actinic keratoacanthomas and squamous cell carcinoma of the skin. Am J Dermatopathol. 1995;174:332-334.
9. Ho T, Horn T, Finzi E. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas. Arch Dermatol. 1991;127:1167-1171.
10. Kannon G, Park HK. Utility of peanut agglutinin in the diagnosis of squamous cell carcinoma and keratoacanthoma. Am J Dermatopathol. 1990;121:31-36.
11. Ariano MC, Wiley EL, Ariano L, et al. H, peanut lectin receptor, and carcinoembryonic antigen distribution in keratoacanthomas, squamous dysplasias, and carcinomas of the skin. J Dermatol Surg Oncol. 1985;11:1076-1083.
12. Clausen OPF, Beigi M, Bolund L, et al. Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic hybridization. J Invest Dermatol. 2002;119:1367-1372.
13. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366:704-707.
14. Tam SW, Shay JW, Pagano M. Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16 Ink-4. Cancer Res. 1994;54:5816-5820.
15. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994;264:436-440.
16. Nobori T, Milura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994;368:753-756.
17. INK4A is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation. Oncogene. 2002;21:2652-2661.
18. 1 arrest. Br J Dermatol. 2003;149:560-565.
19. Hodges A, Smoller BR. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin. Mod Pathol. 2002;115:1121-1125.
20. Patel A, Halliday GM, Cooke BE, Barnetson RS. Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma. Br J Dermatol. 1994;131:789-798.
21. Godbolt AM, Sullivan JJ, Weedon D. Keratoacanthoma with perineural invasion: a report of 40 cases. Australas J Dermatol. 2001;42:168-171.
22. INK4a expression in actinic keratosis and Bowen's disease. Br J Dermatol. 2003;149:1006-1012.